Literature DB >> 91402

Methyl xanthines, adenosine 3',5'-cyclic monophosphate and the spinal transmission of nociceptive information.

A W Duggan, B T Griersmith.   

Abstract

1 In spinal cats anaesthetized with either alpha-chloralose or sodium pentobarbitone, a study was made of the effects of adenosine 3',5'-cyclic monophosphate (cyclic AMP), mono- and di-butyryl cyclic AMP and the methyl xanthines, theophylline and isobutyl methyl xanthine (IBMX), on the responses of neurones of laminae I, IV and V to noxious and innocuous skin stimuli. The compounds were administered from micropipettes positioned in the substantia gelatinosa. IBMX was also given intravenously.2 When administered in the substantia gelatinosa, neither cyclic AMP, its butyryl derivatives, nor the methyl xanthines had any effect on the excitation of neurones of spinal laminae IV and V by noxious heating of the skin or deflection of hairs. When the nociceptive responses of cells had been reduced by electrophoretic morphine, methyl xanthines and cyclic AMP failed to modify the effects of morphine on these deeper neurones. Electrophoretically administered naloxone reversed the effect of morphine.3 Intravenously administered IBMX (1 to 2 mg/kg) produced large transient increases in the firing rate of both C fibres and the excitation of dorsal horn neurones by noxious heating of the skin. These increases coincided with decreases in the mean systemic blood pressure, and probably resulted from increased temperatures being attained in the dermis by each noxious stimulus. When dorsal horn neurones were activated by electrical stimulation of the tibial nerve by a stimulus adequate to excite C fibres, intravenous IBMX produced a small or no increase in the number of spikes per stimulus.4 These results in the spinal cord do not support the hypothesis that the inhibition of synthesis of cyclic AMP is relevant to the analgesic action of morphine in mammals.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 91402      PMCID: PMC2043597     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  18 in total

1.  Morphone abstinence and quasi-abstinence effects after phosphodiesterase inhibitors and naloxone.

Authors:  D L Francis; A C Roy; H O Collier
Journal:  Life Sci       Date:  1975-06-15       Impact factor: 5.037

2.  Morphine antagonises action of prostaglandin in neuroblastoma and neuroblastoma times glioma hybrid cells.

Authors:  J Traber; K Fischer; S Latzin; B Hamprecht
Journal:  Nature       Date:  1975-01-10       Impact factor: 49.962

3.  Cyclic AMP and cyclic GMP may mediate opposite neuronal responses in the rat cerebral cortex.

Authors:  T W Stone; D A Taylor; F E Bloom
Journal:  Science       Date:  1975-03-07       Impact factor: 47.728

4.  Inhibition of acetylcholine release from cholinergic nerves by adenosine, adenine nucleotides and morphine: antagonism by theophylline.

Authors:  J Sawynok; K H Jhamandas
Journal:  J Pharmacol Exp Ther       Date:  1976-05       Impact factor: 4.030

5.  Endorphin from pituitary inhibits cyclic AMP formation in homogenates of neuroblastoma X glioma hybrid cells.

Authors:  A Goldstein; B M Cox; W A Klee; M Nirenberg
Journal:  Nature       Date:  1977-01-27       Impact factor: 49.962

6.  Morphine, enkephalin and the substantia gelatinosa.

Authors:  A W Duggan; J G Hall; P M Headley
Journal:  Nature       Date:  1976-12-02       Impact factor: 49.962

Review 7.  Narcotic analgestics: CNS sites and mechanisms of action as revealed by intracerebral injection techniques.

Authors:  T L Yaksh; T A Rudy
Journal:  Pain       Date:  1978-04       Impact factor: 6.961

8.  Studies on norepinephrine-containing afferents to Purkinje cells of rat cerebellum. 3. Evidence for mediation of norepinephrine effects by cyclic 3',5'-adenosine monophosphate.

Authors:  G R Siggins; B J Hoffer; F E Bloom
Journal:  Brain Res       Date:  1971-02-05       Impact factor: 3.252

9.  Suppression of transmission of nociceptive impulses by morphine: selective effects of morphine administered in the region of the substantia gelatinosa.

Authors:  A W Duggan; J G Hall; P M Headley
Journal:  Br J Pharmacol       Date:  1977-09       Impact factor: 8.739

10.  Absence of morphine antagonism of prostaglandin E1-stimulated [3H]3',5'-cyclic adenosine monophosphate accumulation in a rat brain mince system.

Authors:  J B Katz; G N Catravas
Journal:  Brain Res       Date:  1977-01-21       Impact factor: 3.252

View more
  5 in total

1.  Characterization of the antinociceptive effects of some adenosine analogues in the rat.

Authors:  M Holmgren; J Hedner; T Mellstrand; G Nordberg; T Hedner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-11       Impact factor: 3.000

2.  Classification of adenosine receptors mediating antinociception in the rat spinal cord.

Authors:  J Sawynok; M I Sweeney; T D White
Journal:  Br J Pharmacol       Date:  1986-08       Impact factor: 8.739

3.  A study of the role of cyclic adenosine 3',5'-monophosphate in the depression by opiates and opioid peptides of excitatory junction potentials in the mouse vas deferens.

Authors:  R A North; L V Vitek
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

4.  Cyclic nucleotides and aminophylline produce different effects on nociceptive motor and sensory responses in the rat spinal cord.

Authors:  I Jurna
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-08       Impact factor: 3.000

5.  Morphine and supraspinal inhibition of spinal neurones: evidence that morphine decreases tonic descending inhibition in the anaesthetized cat.

Authors:  A W Duggan; B T Griersmith; R A North
Journal:  Br J Pharmacol       Date:  1980-07       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.